Balanced news tone
News Sentiment
ORNAV sentiment intelligence
Orion Oyj news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
85/100 classification confidence.
directly relevant articles
high-authority source matches
+12.0% over one week, +16.5% over four weeks, trend active, and materially above fair value.
Orion stock holds as investors await the next catalyst
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Orion stock holds as investors await the next catalyst
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Jul 2026 04:45
- Source
- ad-hoc-news.de
Why is Orion Oyj B stock surging today?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jul 2026 10:12
- Source
- Investing.com
45,611 Orion Corporation A shares converted into B shares
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jul 2026 06:00
- Source
- Market source
Orion focuses on pharmaceuticals and animal health as investors watch global peers.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Jul 2026 07:05
- Source
- ad-hoc-news.de
Orion Oyj focuses on pharmaceuticals and global growth
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 08 Jul 2026 10:39
- Source
- ad-hoc-news.de
Is Orion Oyj (HLSE:ORNBV) A Bargain On Its New Nivolumab Biosimilar Deal?
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 08 Jul 2026 01:53
- Source
- simplywall.st
The Dexmedetomidine Orion. A quiet workhorse in modern sedation
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 Jul 2026 09:55
- Source
- ad-hoc-news.de
Orion stock extends its Helsinki listing focus. Investors watch the Finnish drugmaker's steady busin
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 Jul 2026 09:50
- Source
- ad-hoc-news.de
Orion Oyj focuses on pharmaceuticals and diagnostics as investors watch long-term growth
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 04 Jul 2026 07:57
- Source
- ad-hoc-news.de
Orion Oyj focuses on pharmaceuticals and innovation as investors weigh long-term growth
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 02 Jul 2026 10:58
- Source
- ad-hoc-news.de
Orion PharmaStore – Orion bets on a quiet but growing chronic-care channel
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jul 2026 08:35
- Source
- ad-hoc-news.de
Orion Oyj focuses on pharmaceuticals and generics as investors watch global healthcare demand
- Tone
- Neutral 50/100
- Event
- Macro sensitivity
- Published
- 01 Jul 2026 14:13
- Source
- ad-hoc-news.de
Orion prepares for substantial growth amid broader market moves
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 30 Jun 2026 07:00
- Source
- ad-hoc-news.de
Orion Oyj sees BlackRock stake cross 5 percent, shares in focus for Helsinki investors
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 26 Jun 2026 07:00
- Source
- ad-hoc-news.de
Orion Stock - Thursday chart update and technical picture
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Jun 2026 07:00
- Source
- ad-hoc-news.de
What Does BlackRock's Reduced Stake in Orion Corporation Signify
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 05 Jun 2026 16:04
- Source
- Kavout | AI
Inside information: Orion provides outlook for 2026 and
- Tone
- Neutral 50/100
- Event
- Guidance
- Published
- 14 Jan 2026 08:00
- Source
- GlobeNewswire
Orion Oyj Class A Financial Statements – OMXHEX:ORNAV
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Apr 2021 03:24
- Source
- TradingView